Please login to the form below

Not currently logged in
Email:
Password:

Concept Life Sciences adds to its team

Matilda Bingham and David Higton join its Alderley Park site

Matilda BinghamIntegrated drug discovery, development and analytical services company Concept Life Sciences has appointed Matilda Bingham as site director of its Alderley Park unit based in Cheshire, UK.

With over 15 years’ experience in the pharmaceutical industry in both biotech and pharma environments, Bingham joins Concept from Rex Pharma, where she held positions as head of research operations and executive director of oncology and immunology.

Prior to this, Bingham has also previously worked for MSD Research Laboratories.

She said: “I am looking forward to applying my own drug discovery experience alongside the already established expertise within the team to expand integrated drug discovery services at Concept, both at the Alderley Park Site and in collaboration with the Company’s other sites.”

David HigtonAdditionally, David Higton joins Concept as its biotransformation and metabolite identification expert.

Higton, who has over 34 years of expertise in bioanalytical and biotransformation studies, has spent 23 years at Glaxo Group Research – now GlaxoSmithKline – where he supported pre-clinical, clinical and discovery investigations for both non-GLP and GLP studies.

He most recently held the role of head of analytical sciences at Cyprotex and prior to this, he was analytical team leader at Redx Pharma.

Higton has also held roles for AstraZeneca and Xceleron.

Phillip Payne, chief operating officer at Concept Life Sciences, said: “With several years’ experience of managing multidisciplinary research projects in a pharmaceutical company environment, we are delighted to have appointed Matilda to head up our new Alderley Park site.

“We are also pleased to welcome David, whose expertise will be a valuable addition to the analytical team.”

30th April 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics